Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Eun Sook Bae; Dong Moon Yeum

doi:10.7475/kjan.2015.27.2.223

Articles

Page Path

Original Article

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Eun Sook Bae¹, Dong Moon Yeum²

Korean Journal of Adult Nursing 2015;27(2):223-232.
Published online: April 30, 2015

DOI: https://doi.org/10.7475/kjan.2015.27.2.223

¹Department of Nursing Science, Dong-Eui University, Busan

²Department of Social Welfare, International University of Korea, Jinju, Korea

Corresponding author: Bae, Eun Sook Department of Nursing, Dong-Eui University, 995 Eomgwang-ro, Busanjin-gu, Busan 614-714, Korea. Tel: +82-51-890-2861, Fax: +82-505-182-6876, E-mail: baesukkr3966@deu.ac.kr

• Received: February 24, 2015 • Accepted: April 11, 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

22 Views
0 Download
6 Crossref

prev next

Full Article

Download PDF

Abstract
REFERENCES

Abstract

Purpose
Parkinson's disease (PD) has a high incidence of psychiatric comorbidity, specifically depression and anxiety. This study examined the effectiveness of group cognitive behavioral therapy (CBT) in treating depression and anxiety.
Methods
The study included 42 participants, aged between 52 and 77 years, who were diagnosed with idiopathic Parkinson's disease (IPD) and reported suffering from depression and anxiety. Patients were attending a department of outpatient neurology at D University Schools of Medicine in B Metropolitan city. A structured telephone-administered cognitive behavioral therapy was conducted for eight weeks. A repeated measure ANOVA was used to analyze results at pretest, post-test, and four weeks follow up.
Results
According to service method, there were significant differences between the two groups in depression, anxiety and stigma was significant difference between time (p<.05). Analysis of the interaction between time and service method revealed significant differences in depression and anxiety (p<.05).
Conclusion
The results suggest that telephone-administered cognitive behavioral therapy may be effective and may provide opportunity to adapt to individual needs for treating depression and anxiety in patients with Parkinson's disease.
Key Words: Parkinson's disease; Depression; Anxiety; Cognitive Behavioral Therapy (CBT)

Figure 1.

Research design of the study.

Table 1.

Homogeneity of Demographic Characteristics and Disease Characteristics between the Two Groups (N=42)

Variables	Categories	Exp. (n=19)	Cont. (n=23)	Fisher exact or t	p
Variables	Categories	n (%) or M±SD	n (%) or M±SD	Fisher exact or t	p
Gender	Female	15 (78.9)	17 (73.9)	0.145^†	1.000
Gender	Male	4 (21.1)	6 (26.1)	0.145^†	1.000
Age (year)		60.9±6.13	68.3±7.15	9.181	.080
	≤49	0 (0.0)	0 (0.0)
	50~59	7 (36.3)	3 (13.0)
	60~69	9 (47.4)	8 (34.7)
	≥70	3 (15.8)	12 (52.1)
Education level	No	0 (0.0)	5 (21.7)	5.052	.289
	Elementary	4 (21.1)	5 (21.7)
	Middle school	8 (42.1)	7 (30.4)
	High school	4 (21.1)	3 (13.0)
	college ≥	3 (15.8)	3 (13.0)
Marital state	Married (live spouse)	15 (78.9)	18 (78.3)	0.303	1.000
	Unmarried	0 (0.0)	0 (0.0)
	Divorce	2 (10.5)	2 (8.7)
	Separation	0 (0.0)	0 (0.0)
	Bereavement	2 (10.5)	3 (13.0)
Average monthly income (10,000 won)	≤50	10 (52.6)	9 (39.1)	5.122	.421
	≤100	3 (15.8)	4 (17.4)
	≤150	0 (0.0)	4 (17.4)
	≤200	2 (10.5)	1 (4.3)
	≤250	2 (10.5)	1 (4.3)
	≥251	2 (10.5)	4 (17.4)
Occupation	Yes	1 (5.3)	5 (21.7)	2.307	.197
Occupation	No	18 (94.7)	18 (78.3)	2.307	.197
Duration of illness (year)	≤1	1 (5.6)	3 (13.0)	2.294	.885
	≤3	7 (38.9)	5 (21.7)
	≤6	5 (27.8)	7 (30.4)
	≤9	2 (11.1)	4 (17.4)
	≤12	2 (11.1)	2 (8.7)
	12 ＞	1 (5.6)	2 (8.7)
Age of onset (year)	≤49	4 (16.7)	1 (4.3)	5.489	.514
	≤59	8 (44.4)	6 (26.1)
	≤69	6 (33.3)	10 (43.5)
	≥70	1 (5.6)	6 (26.1)
H & Y stage S & E ADL MMSE		2.39±0.49	2.37±0.53	0.159	.874
		82.11±8.55	79.05±12.21	0.908	.370
		28.53±1.26	26.78±2.45	2.970	.005

H & Y stage=Hoehn & Yahr stage; S & E ADL=Schwab & England activities of daily living; MMSE=mini-mental state examination; Exp.=experimental group, Cont.=control group;

^†by x²-test (p ＜.05),

Table 2.

Homogeneity Test of Study Variables between the Two Groups (N=42)

variables	Exp. (n=19)	Cont. (n=23)	t	p
variables	M±SD	M±SD	t	p
Depression	20.79±7.84	24.17±9.51	1.73	.222
Anxiety	53.42±8.30	54.96±8.50	2.24	.560
CIAS	58.58±17.41	60.65±19.13	2.82	.718

Exp.=experimental group, Cont.=control group; CIAS=chronic illness anticipated stigma.

Table 3.

Repeated Measure ANOVA of Depression, Anxiety and CIAS between the Two Groups (N=42)

Variables	Groups	Pretest	Posttest 1	Posttest 2	p for time differences		F (p)	Sources	F	p
Variables	Groups	M±SD	M±SD	M±SD	(Post 1/ Pre)	(Post 2/ Pre)	F (p)	Sources	F	p
Depression	Exp.	20.79±7.84	17.68±11.85	22.05±12.69	.067	.084	0.80 (.457)	Group	5.70	.022
	Cont.	24.17±9.51	29.83±13.47	28.14±13.72			1.27 (.288)	Time	1.05	.349
	p for group	.222	.004	.155				Time*Group	4.22	.022
	differences
Anxiety	Exp.	53.42±8.30	44.26±14.06	44.26±13.65	.003	.007	3.51 (.037)	Group	6.67	.014
	Cont.	54.96±8.51	56.52±11.10	53.43±13.63			0.34 (.712)	Time	4.30	.017
	p for group	.560	.003	.040				Time*Group	4.94	.010
	differences
CIAS	Exp.	58.58±17.41	45.11±16.80	42.95±15.48	.006	.001	4.96 (.011)	Group	2.55	.119
	Cont.	60.65±19.13	56.09±18.97	50.24±14.59			1.89 (.160)	Time	12.60	＜ .001
	p for group	.718	.056	.134				Time*Group	1.60	.208
	differences

CIAS=chronic illness anticipated stigma; Exp.=experimental group; Cont.=control group; Pre=Pretest; Post 1=Posttest 1: week after intervention trials ended; Post 2=Posttest 2: 4 weeks after intervention trials ended.

REFERENCES

1.Pandya M1, Kubu CS. Giroux ML Parkinson's disease: not just a movement disorder. Cleveland Clinical Journal of Medicine. 2008;75(12):856-64. http://dx.doi.org/10.3949/ccjm.75a.07005.
2.McDonald WM, Righard IH, DeLong MR. Prevalence, etiology and treatment ofdepressionin Parkinson's disease. Society of Biological Psychiatry. 2003;54(3):363-75. http://dx.doi.org/10.1016/S0006-3223(03)00530-4.
Article
3.Cubo E, Bernard B, Leurgans S, Raman R. Cognitive and motor function in patients with Parkinson's disease with and without depression. Clinical Neuropharmacology. 2000;23(6):331-4.
4.Veazey C, Aki SOE, Cook KJ, Lai E, Kunik ME. Prevalence and treatment of depression in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences. 2005;17(3):310-23. http://dx.doi.org/10.1176/jnp.17.3.310.
Article
5.Veazy C, Cook KF, Stanley M, Lai EC, Junik ME. Telephone-administered cognitive behavioral therapy: a case of anxiety and depression in Parkinson's disease. Journal of Clinical Psychologic Medical Settings. 2009;16:243-53. http://dx.doi.org/10.1007/s10880-009-9167-6.
6.Brooks DJ, Doder M. Depression in Parkinson's disease. Current Opinion in Neurology. 2001;14:465-70.
Article
7.Starkstein S, Dragovic M, Jorge R, Brockman1 S, Merello M, Robinson RG, et al. Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Movement Disorders. 2011;26(12):2239-45. http://dx.doi.org/10.1002/mds.23836.
8.Ragnhild SH, Kjersti RL, Kathleen MG, Tom W, Martin E, Knut W, et al. The clinical effectiveness of web-based cognitive behavioral therapy with face-to-face therapist support for depressed primary care patients: randomized controlled trial. Journal of Medical Internet Research. 2013;15(8):e153http://dx.doi.org/10.2196/jmir.2714.
Article
9.Wrigley S, Jackson H, Judd F, Komiti A. The role of stigma and attitudes towards help seeking for mental health problems in a rural town. Australian & New Zealand Journal of Psychiatry. 2005;39(6):514-21. http://dx.doi.org/10.1111/j.1440-1614.2005.01612.x.
10.Weintraub D, Moberg PJ, Duda JE, Katz IR, Stem MB. Recognition and treatment of depression in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology. 2003;16(3):178-83. http://dx.doi.org/10.1177/0891988703256053.
Article
PDF
11.Shimotsu S, Horikawab N, Emurac R, Ishikawad SI, Nagaob A, Ogataf A, et al. Effectiveness of group cognitive-behavioral therapy in reducing self-stigma in Japanese psychiatric patients. Asian Journal of Psychiatry. 2014;10:39-44. http://dx.doi.org/10.1016/j.ajp.2014.02.006.
12.Simpson J, McMillan H, Reeve D. Reformulating psycholo-gicaldifficulties inpeople withParkinson'sdisease: the potential of a social relational approach to disablism. Parkinson's Disease 2013;Article ID 608562:.1-8. http://dx.doi.org/10.1155/2013/608562.
Article
PDF
13.Beck JSCognitive therapy: basics and beyond. New York: Guilford press; 1995.
14.Chambless DL, Ollendick TH. Empirically supported psychologic intervention: controversies and evidence. Annual Review of Psycology. 2001;52:685-716. http://dx.doi.org/10.1177/10.1146/annurev.psych.52.1.685.
15.Yeh AH, Taylor S, Thordarson DS, Corcoran KM. Efficacy of telephone-administered cognitive behavioral therapy for obsessive-compulsive spectrum disorders: case studies. cognitive behavioral therapy. 2003;32(2):75-81. http://dx.doi.org/10.1080/16506070302323.
16.Ludman E, Simon GE, Tutty S, VonKorff M. Arandomizedtrial of telephone psychotherapy and pharmacotherapy for depression: continuation durability of effects. Journal of Counselling and Clinical Psychology. 2007;75(2):257-66. http://dx.doi.org/10.1037/0022-006X.75.2.257.
17.Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-42.
Article
18.Fahn SMarsden C, Jennifer P, Teychenne P. Eds. Recent development in Parkinson's disease. Florham Park NJ: Macmillan Health care Information; 1987. p. 2.
19.Beck ATDepression: clinical, experimental and theoretical aspects. New York: Harper & Row; 1967.
20.Lee YHThe relations between attributionalstyle, life events, event attribution, hopelessness and depression. [dissertation]. Seoul National University; 1992.
21.Spielberger CDManual for the State-trait anxiety inventory. Palo alto, CA: Consulting Psychologist Press; 1970.
22.Kim JTCorrelation between trait anxiety and sociality: Spiel-berger's STA. [dissertation]. Seoul: Korea University; 1978.
23.Kurzban R, Leary MR. Evolutionary origins of stigmatization: the functions of social exclusion. PsychologicalBulletin. 2001;127:187-208. http://dx.doi.org/10.1037/0033-2909.127.2.187.
Article
24.Earnshaw VA, Quinn DM, Kalichman SC, Park CL. Development and psychometric evaluation of the chronic illness anticipated stigma scale. Journal of Behavioral Medicine. 2013;36930:270-82. http://dx.doi.org/10.1007/s10865-012-9422-4.
Article
PDF
25.Robert LL, Stephen JFLata KM. Treatment plans and interventions for depression and anxiety disorders. The Guilford Press; Second Edition. 2011.
26.Yang S, Sajatovic M, Walter BL. Psychosocial intervention for depression and anxiety in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology. 2012;25(2):113-21. http://dx.doi.org/10.1177/0891988712445096.
27.Simmon GE, Ludman EJ, Opeskaliski BH. Randomized trialof telephone care management program: for outpatient starting antidepressant treatment. Psychiatric Services. 2006;57(10):1441-5.
Article
28.Dobkin RD, Allen LA, Menza M. Cognitive behavioral therapy for depression in Parkinson's disease: a pilot study. Movement Disorders. 2007;22(7):946-52. http://dx.doi.org/10.1002/mds.21455.
Article
29.Dobkin RD, Allen LA, Menza M, Gara MA, Mark MH, Jade Tiu J. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. America Journal of Psychiatry. 2011;168(10):1066-74. http://dx.doi.org/10.1176/appi.ajp.2011.10111669.
Article
30.Cole K, Vaughan FL. The feasibility of using cognitive behavioral therapy for depression associated with Parkinson's disease: a literature review. Parkinsonism & Related Disorders. 2005;11(5):270-6. http://dx.doi.org/10.1016/j.parkreldis.2005.03.002.

Figure & Data

References

Citations

Citations to this article as recorded by

Efficacy of cognitive behavioral therapy for anxiety and depression in Parkinson’s disease patients: an updated systematic review and meta-analysis
Asmaa Zakria Alnajjar, Moaz Elsayed Abouelmagd, Abdulrahman Krayim, Maickel AbdelMeseh, Nagham Bushara, Yehia Nabil
Neurological Sciences.2024; 45(11): 5277. CrossRef
Effects of Task-Based LSVT-BIG Intervention on Hand Function, Activity of Daily Living, Psychological Function, and Quality of Life in Parkinson’s Disease: A Randomized Control Trial
YoungSeok Choi, DeokJu Kim, Kuan Lin Chen
Occupational Therapy International.2022; 2022: 1. CrossRef
Concept Analysis of Self-stigma in Patients with Tuberculosis
Seonmi Yeom, Jeong Hee Kang, Youngran Yang
Journal of Korean Academy of Community Health Nursing.2021; 32(3): 312. CrossRef
Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment
Jianing Chen, Peikun He, Yuhu Zhang, Yuyuan Gao, Yihui Qiu, You Li, Qingxi Zhang, Limin Wang, Zhiheng Huang, Jiehao Zhao, Kun Nie, Lijuan Wang
International Journal of Neuroscience.2021; 131(4): 411. CrossRef
Personalized Telemedicine for Depression in Parkinson’s Disease: A Pilot Trial
Roseanne D. Dobkin, Alejandro Interian, John Logan Durland, Michael A. Gara, Matthew A. Menza
Journal of Geriatric Psychiatry and Neurology.2018; 31(4): 171. CrossRef
Factors that affect Chronic Illness Anticipated Stigma(CIAS) in patients with Parkinson's disease
Mi-Jung Kim, Eun-Sook Bae
Korean Journal of Health Education and Promotion.2015; 32(3): 121. CrossRef

Cite

CITE

export

Copy Download

Format
XML Download

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Korean J Adult Nurs. 2015;27(2):223-232. Published online April 30, 2015

DOI: https://doi.org/10.7475/kjan.2015.27.2.223

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Korean J Adult Nurs. 2015;27(2):223-232. Published online April 30, 2015

DOI: https://doi.org/10.7475/kjan.2015.27.2.223

Figure

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Figure 1. Research design of the study.

Figure 1.

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Table 1.

Homogeneity of Demographic Characteristics and Disease Characteristics between the Two Groups (N=42)

Variables	Categories	Exp. (n=19)	Cont. (n=23)	Fisher exact or t	p
Variables	Categories	n (%) or M±SD	n (%) or M±SD	Fisher exact or t	p
Gender	Female	15 (78.9)	17 (73.9)	0.145^†	1.000
Gender	Male	4 (21.1)	6 (26.1)	0.145^†	1.000
Age (year)		60.9±6.13	68.3±7.15	9.181	.080
	≤49	0 (0.0)	0 (0.0)
	50~59	7 (36.3)	3 (13.0)
	60~69	9 (47.4)	8 (34.7)
	≥70	3 (15.8)	12 (52.1)
Education level	No	0 (0.0)	5 (21.7)	5.052	.289
	Elementary	4 (21.1)	5 (21.7)
	Middle school	8 (42.1)	7 (30.4)
	High school	4 (21.1)	3 (13.0)
	college ≥	3 (15.8)	3 (13.0)
Marital state	Married (live spouse)	15 (78.9)	18 (78.3)	0.303	1.000
	Unmarried	0 (0.0)	0 (0.0)
	Divorce	2 (10.5)	2 (8.7)
	Separation	0 (0.0)	0 (0.0)
	Bereavement	2 (10.5)	3 (13.0)
Average monthly income (10,000 won)	≤50	10 (52.6)	9 (39.1)	5.122	.421
	≤100	3 (15.8)	4 (17.4)
	≤150	0 (0.0)	4 (17.4)
	≤200	2 (10.5)	1 (4.3)
	≤250	2 (10.5)	1 (4.3)
	≥251	2 (10.5)	4 (17.4)
Occupation	Yes	1 (5.3)	5 (21.7)	2.307	.197
Occupation	No	18 (94.7)	18 (78.3)	2.307	.197
Duration of illness (year)	≤1	1 (5.6)	3 (13.0)	2.294	.885
	≤3	7 (38.9)	5 (21.7)
	≤6	5 (27.8)	7 (30.4)
	≤9	2 (11.1)	4 (17.4)
	≤12	2 (11.1)	2 (8.7)
	12 ＞	1 (5.6)	2 (8.7)
Age of onset (year)	≤49	4 (16.7)	1 (4.3)	5.489	.514
	≤59	8 (44.4)	6 (26.1)
	≤69	6 (33.3)	10 (43.5)
	≥70	1 (5.6)	6 (26.1)
H & Y stage S & E ADL MMSE		2.39±0.49	2.37±0.53	0.159	.874
		82.11±8.55	79.05±12.21	0.908	.370
		28.53±1.26	26.78±2.45	2.970	.005

H & Y stage=Hoehn & Yahr stage; S & E ADL=Schwab & England activities of daily living; MMSE=mini-mental state examination; Exp.=experimental group, Cont.=control group;

^†by x²-test (p ＜.05),

Table 2.

Homogeneity Test of Study Variables between the Two Groups (N=42)

variables	Exp. (n=19)	Cont. (n=23)	t	p
variables	M±SD	M±SD	t	p
Depression	20.79±7.84	24.17±9.51	1.73	.222
Anxiety	53.42±8.30	54.96±8.50	2.24	.560
CIAS	58.58±17.41	60.65±19.13	2.82	.718

Exp.=experimental group, Cont.=control group; CIAS=chronic illness anticipated stigma.

Table 3.

Repeated Measure ANOVA of Depression, Anxiety and CIAS between the Two Groups (N=42)

Variables	Groups	Pretest	Posttest 1	Posttest 2	p for time differences		F (p)	Sources	F	p
Variables	Groups	M±SD	M±SD	M±SD	(Post 1/ Pre)	(Post 2/ Pre)	F (p)	Sources	F	p
Depression	Exp.	20.79±7.84	17.68±11.85	22.05±12.69	.067	.084	0.80 (.457)	Group	5.70	.022
	Cont.	24.17±9.51	29.83±13.47	28.14±13.72			1.27 (.288)	Time	1.05	.349
	p for group	.222	.004	.155				Time*Group	4.22	.022
	differences
Anxiety	Exp.	53.42±8.30	44.26±14.06	44.26±13.65	.003	.007	3.51 (.037)	Group	6.67	.014
	Cont.	54.96±8.51	56.52±11.10	53.43±13.63			0.34 (.712)	Time	4.30	.017
	p for group	.560	.003	.040				Time*Group	4.94	.010
	differences
CIAS	Exp.	58.58±17.41	45.11±16.80	42.95±15.48	.006	.001	4.96 (.011)	Group	2.55	.119
	Cont.	60.65±19.13	56.09±18.97	50.24±14.59			1.89 (.160)	Time	12.60	＜ .001
	p for group	.718	.056	.134				Time*Group	1.60	.208
	differences

Table 1. Homogeneity of Demographic Characteristics and Disease Characteristics between the Two Groups (N=42)

H & Y stage=Hoehn & Yahr stage; S & E ADL=Schwab & England activities of daily living; MMSE=mini-mental state examination; Exp.=experimental group, Cont.=control group;

†

by x²-test (p ＜.05),

Table 2. Homogeneity Test of Study Variables between the Two Groups (N=42)

Exp.=experimental group, Cont.=control group; CIAS=chronic illness anticipated stigma.

Table 3. Repeated Measure ANOVA of Depression, Anxiety and CIAS between the Two Groups (N=42)

Articles

Page Path

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

Full Article

Abstract

REFERENCES

Figure & Data

References

Citations

CITE

Download Citation

Format:

Include:

Figure

Figure 1.

Table 1.

Table 2.

Table 3.

ABOUT

BROWSE ARTICLES

EDITORIAL POLICY

FOR CONTRIBUTORS